Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis

European Journal of Immunology

Volumn 36, Issue 11, 2006, Pages 2868-2874

  Uyttenhove, Catherine ^a,b   Van Snick, Jacques ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

Autoimmunity; Cytokines; EAE; IL 17; Vaccination

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17A; INTERLEUKIN 17A ANTIBODY; MONOCLONAL ANTIBODY; OVALBUMIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SELECTIVITY; DRUG SPECIFICITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; AUTOANTIBODIES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-17; MICE; MICE, INBRED STRAINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 33751243318     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636662     Document Type: Article

References (39)

1. Rouvier, E., Luciani, M. F., Mattei M. G., Denizot, F. and Golstein, P., CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 1993.150: 5445-5456.
2. Ferretti, S., Bonneau, O., Dubois, G. R., Jones, C. E. and Trifilieff, A., IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003. 170: 2106-2112.
3. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003. 278: 1910-1914.
4. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat. Immunol 2005. 6: 1123-1132.
5. Park, H., Li Z., Yang, X. O., Chang, S. H., Nurieva, P, Wang, Y. H., Wang, Y., Hood, L. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
6. Langrish, C. L, Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
7. Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K. et al., Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002. 17. 375-387.
8. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179-189.
9. Schwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S. et al., IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 1998. 161: 6383-6389.
10. Witowski, J., Pawlaczyk K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A. et al., IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 2000. 165: 5814-5821.
11. Huang, W., Na, L., Fidel, P. L. and Schwarzenberger, P., Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 2004. 190: 624-631.
12. Hellings, P. W., Kasran, A., Liu, Z., Vandekerckhove, P., Wuyts, A., Overbergh, L, Mathieu, C. and Ceuppens, J. L. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell. Mol. Biol. 2003. 28: 42-50.
13. + T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J. Immunol. 2003. 170: 1958-1963.
14. Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak K., Klimczak, E., Chwalinska-Sadowska, H. and Maslinski, W., High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 2000. 164: 2832-2838.
15. Matusevicius, D., Kivisakk P., He, B., Kostulas, N., Ozenci V., Fredrikson, S. and Link, H., Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999. 5: 101-104.
16. Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A. and Bos, J. D., Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 1998. 111: 645-649.
17. Dalum I., Jensen, M. R., Hindersson, P., Elsner, H. I. and Mouritsen, I., Breaking of B cell tolerance toward a highly conserved self protein. J. Immunol. 1996. 157. 4796-4804.
18. Richard, M., Grencis, R. K., Humphreys, N. E., Renauld, J.-C. and Van Snick J., Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 2000. 97: 767-772.
19. Uyttenhove, C., Arendse, B., Stroobant, V., Brombacher, F. and Van Snick, J., Development of an anti-IL-12 p4O auto-vaccine: protection in experimental autoinumme encephalomyelitis at the expense of increased sensitivity to infection. Eur. J. Immunol. 2004. 34: 3572-3581.
20. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
21. Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Welshaupt, A., Toyka, K. V. and Gold, R., Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 2005. 237: 123-130.
22. Tan, S. L., Zhao, J., Bi, C., Chen, X. C., Hepburn, D. L., Wang, J., Sedgwick, J. D. et al., Resistance to experimental autoimmmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 2006. 176: 2872-2879.
23. Svenson, M., Hansen, M. H., Thomsen, A. R., Diamant, NL, Nansen, A., Rieneck, K., Otterness, I. G. and Bendtzen, K., Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha. J. Immunol. Methods 2000. 236: 1-8.
24. Roberts, W. K., Livingston, P. O., Agus, D. B., Pinilla-Ibarz, J., Zelenetz, A. and Scheinberg, D. A., Vaccination with CD20 peptides induces a biologically active, specific immune response in mice. Blood 2002. 99: 3748-3755.
25. Dalum, I., Butler, D. M., Jensen, M. R., Hindersson, P., Steinaa, L., Waterston, A. M., Grell, S. N. et al., Therapeutic antibodies elicited by immunization against TNF-alpha. Nat. Biotechnol. 1999. 17. 666-669.
26. Hertz, M., Mahalingam, S., Dalum, I., Klysner, S., Mattes, J., Neisig, A., Mouritsen, S. et al., Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J. Immunol. 2001. 167: 3792-3799.
27. Galle, P., Hougs, L., Barington, T., Svenson, M., Svejgaard, A., Thomsen, A. R., Bendtzen, K. and Hansen, M. B., Knocking out IL-6 by vaccination. Eur. J. Immunol. 2004. 34: 291-300.
28. Youssef, S., Wildbaum, G., Maor, G., Lanir, N., Gour-Lavie, A., Grabie, N. and Karin, N., Long-lasting protective immunity to experimental auto-immune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines. J. Immunol. 1998. 161: 3870-3879.
29. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J., Joosten, L. A. and van den Berg, W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004. 50: 650-659.
30. Linden, A., Rationale for targeting interleukin-17 in the lungs. Curr. Opin. Investig. Drugs 2003. 4: 1304-1312.
31. Nielsen O. H., Kirman, L, Rudiger, N., Hendel, J. and Vainer, B., Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 2003. 38: 180-185.
32. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A. et al., IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006. 116: 1310-1316.
33. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K, Araki, Y., Bamba, T. and Fujiyama, Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003. 52: 65-70.
34. Ishizu, T., Osoegawa, M., Mei F. J., Kikuchi, H., Tanaka, M., Takakura, Y., Minohara, M. et al., Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005. 128: 988-1002.
35. Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P. G. and Simpson, R. J., Purification and NH2-terminal amino acid sequence of a new T cell-derived lymphokine with growth factor activity for B cell hybridomas. Proc. Natl. Acad. Sci. USA 1986. 83: 9679.
36. Benchetrit, F., Ciree A., Vives, V., Warnier, G., Gey A., Sautes-Fridman, C., Fossiez, F. et al., Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 2002. 99: 2114-2121.
37. Weinberg, A. D., Wegmann, K. W., Funatake, C. and Whitham, R. H., Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 1999. 162: 1818-1826.
38. Heremans, H., Dillen, C., Groenen, M., Matthys, P. and Billiau, A., Role of endogenous interleukin-12 (IL-12) in induced and spontaneous relapses of experimental autoimmune encephalomyelitis in mice. Eur. Cytokine Netw. 1999. 10: 171-180.
39. Uyttenhove, C., Simpson, R. and Van Snick, J., Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc. Natl. Acad. Sci. USA 1988. 85: 6934-6938.